查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574960

腹腔感染市场，按诊断、按应用、按治疗、按国家和地区划分 - 2024-2032 年行业分析、市场规模、市场份额和预测

Intra-Abdominal Infections Market, By Diagnosis, By Application, By Treatment, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年腹腔感染市场规模为 225.9043 亿美元，2024 年至 2032 年复合年增长率为 8.90%。

腹腔感染市场-市场动态

抗生素抗药性的上升推动了对先进治疗方案的需求。

抗生素抗药性的上升增加了对更好的腹内感染治疗方法的需求。随着标准抗生素的有效性降低，医疗保健提供者难以控制这些感染。美国疾病管制与预防中心 (CDC) 报告称，美国每年发生近 300 万例抗生素抗药性感染，凸显了对新疗法的迫切需求。这个问题不仅影响患者的健康，也对医疗保健系统造成沉重压力。

为此，研究人员和製药公司正在研究新的解决方案，包括新型抗生素和替代疗法。我们的目标是开发这些先进的治疗方法，以改善患者的治疗效果并解决传统方法无法治疗的感染。这种转变对于在抵抗力不断上升的情况下确保更好的医疗保健至关重要。

腹腔内感染市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.90% 左右的复合年增长率成长

根据治疗细分，预计 β-内酰胺将在 2023 年显示出最大的市场份额

依应用细分，2023年腹腔内脓疡为主导类型

基于诊断细分，电脑断层扫描（CT）是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

腹腔内感染市场細項分析：

全球腹腔感染市场根据诊断、应用、治疗和区域进行细分。

根据治疗方法，市场分为三类：氯霉素、β内酰胺、喹诺酮类和氨基糖苷类。在腹腔内感染市场，β-内酰胺是领先的治疗选择。它们很受欢迎，因为它们可以有效地针对多种细菌，包括通常与这些感染相关的革兰氏阳性和革兰氏阴性细菌。

β-内酰胺类药物，如青霉素和头孢菌素，由于其有效性和良好的安全性记录，通常是治疗的首选。它们还可以轻鬆穿透组织，从而有效对抗腹内细菌。随着越来越多的手术进行，导致感染率上升，对 β-内酰胺酶的需求持续增长，巩固了其在该细分市场的领先地位。

市场依应用分为五类：腹内脓疡、阑尾炎、憩室炎、腹泻、食物中毒、幽门螺旋桿菌感染等。在腹内感染市场中，最主要的部分是腹内脓疡。这些在临床环境中很常见，通常是作为阑尾炎和憩室炎等疾病的併发症而发生。腹内脓疡可能导致败血症等问题，因此快速有效的治疗至关重要。治疗这些感染的手术和抗生素治疗的需求也推动了市场的成长。

腹腔内感染市场 - 地理洞察

腹腔内感染市场最大的地区是北美洲。该地区拥有大量医院和先进的医疗保健系统，可支持这些感染的诊断和治疗。外科手术的增加和肥胖盛行率的增加导致腹腔内感染的增加。

在主要医疗保健公司的推动下，新疗法的研究和发展也很活跃。患者可以获得抗生素和其他疗法。由于感染管理意识的增强和一些因素的影响，北美市场预计将成长。

腹腔内感染市场-竞争格局：

腹腔内感染市场有许多专注于开发针对这些疾病的有效治疗方法的参与者。默克公司在一系列抗生素和创新疗法方面处于领先地位。辉瑞公司提供多种有效药物，而阿斯特捷利康则以其在该领域的研究而闻名。

艾伯维公司（AbbVie Inc.）专注于对抗感染的标靶疗法，拜耳公司（Bayer AG）提供全面治疗和支持性护理。葛兰素史克（GlaxoSmithKline）也致力于投资新药发现。随着人们对腹腔内感染的认识不断增强，这些公司竞相改进现有产品并推出新疗法，推动市场成长。

最新进展：

2024 年 1 月，NPPA 降低了 Cipla 和 Wockhardt 专利到期后抗生素的价格，旨在提高患者的可及性和负担能力。

2023年1月，BDR Pharmaceuticals推出了一种新的仿製药抗生素头孢他啶+阿维巴坦，旨在对抗革兰氏阴性菌感染。这种组合旨在增强针对具有挑战性的细菌病原体的治疗选择，解决对抗生素抗药性日益增长的担忧。

目录

第一章：腹腔内感染市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 腹腔内感染诊断市场片段
    • 按应用分類的腹内感染市场片段
    • 腹腔内感染治疗市场片段
    • 按国家/地区分類的腹腔内感染市场片段
    • 按地区分類的腹腔内感染市场片段
  • 竞争洞察

第 3 章：腹腔内感染主要市场趋势

  • 腹腔内感染市场驱动因素
    • 市场驱动因素的影响分析
  • 腹腔内感染市场限制
    • 市场限制影响分析
  • 腹腔内感染市场机会
  • 腹腔感染市场未来趋势

第 4 章：腹腔内感染产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：腹腔内感染市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：腹腔内感染市场格局

  • 2023 年腹内感染市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：腹腔内感染市场 - 透过诊断

  • 概述
    • 透过诊断进行细分市场份额分析
    • 腹部X光检查
    • 血液检查
    • 电脑断层扫描 (CT)
    • 超音波
    • 其他的

第 8 章：腹腔内感染市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 腹内脓肿
    • 阑尾炎
    • 憩室炎
    • 腹泻
    • 食物中毒
    • 幽门螺旋桿菌感染
    • 其他的

第 9 章：腹腔内感染市场 - 依治疗方法

  • 概述
    • 按处理方式分類的细分市场占有率分析
    • 氯霉素
    • β内酰胺
    • 奎诺酮类
    • 氨基糖苷类
    • 其他的

第 10 章：腹腔内感染市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美腹腔感染主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按诊断）
    • 北美市场规模和预测（按应用）
    • 北美市场规模与预测（以不同处理方式）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲腹腔感染主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（透过诊断）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按处理方式）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区腹腔感染主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模及预测（依诊断）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（以不同处理方式）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲腹腔感染主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按诊断）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（以不同处理方式）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲腹腔感染主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按诊断）
    • 中东和非洲市场规模及预测（按应用）
    • 中东及非洲市场规模及预测（依不同处理方式）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 腹腔内感染产业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • Merck & Co., Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Allergan (AbbVie)
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • Sanofi SA
    • F. Hoffmann-La Roche Ltd
    • Johnson & Johnson
    • Basilea Pharmaceutica Ltd
    • Shionogi & Co., Ltd.
    • Achaogen, Inc.
    • Melinta Therapeutics, Inc.
    • Tetraphase Pharmaceuticals, Inc.
    • The Medicines Company
    • Dr. Reddy's Laboratories Ltd

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4001

REPORT HIGHLIGHT

Intra-Abdominal Infections Market size was valued at USD 22,590.43 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The intra-abdominal infections market involves products and treatments for infections occurring inside the abdomen. These infections can affect organs like the stomach, intestines, and liver. They are often caused by bacteria and can lead to serious health issues if not treated promptly. The market includes antibiotics, surgical procedures, and medical devices used to manage these infections. With rising cases of obesity and other health conditions, the demand for effective treatments is growing. Overall, this market plays a crucial role in improving patient outcomes and healthcare quality.

Intra-Abdominal Infections Market- Market Dynamics

Rising antibiotic resistance fuels the demand for advanced treatment options.

Rising antibiotic resistance is increasing the demand for better treatments for intra-abdominal infections. As standard antibiotics become less effective, healthcare providers struggle to manage these infections. The Centres for Disease Control and Prevention (CDC) report that nearly 3 million antibiotic-resistant infections happen in the U.S. each year, highlighting the urgent need for new therapies. This issue not only affects patients' health but also puts a heavy strain on healthcare systems.

In response, researchers and pharmaceutical companies are working on new solutions, including novel antibiotics and alternative therapies. The goal is to develop these advanced treatments to improve patient outcomes and tackle infections that traditional methods can't manage anymore. This shift is crucial for ensuring better healthcare in the face of rising resistance.

Intra-Abdominal Infections Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Treatment segmentation, Beta-lactams was predicted to show maximum market share in the year 2023

Based on Application segmentation, Intra-Abdominal Abscesses was the leading type in 2023

Based on Diagnosis segmentation, Computed Tomography (CT) was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Intra-Abdominal Infections Market- Segmentation Analysis:

The Global Intra-Abdominal Infections Market is segmented based on Diagnosis, Application, Treatment, and Region.

The market is divided into three categories based on Treatment: Chloramphenicol, Beta Lactams, Quinolones, and Aminoglycosides. In the Intra-Abdominal Infections market, Beta-lactams are the leading treatment option. They are popular because they effectively target a wide range of bacteria, including both gram-positive and gram-negative types commonly associated with these infections.

Beta-lactams, such as penicillin and cephalosporins, are often the first choice for treatment due to their effectiveness and good safety record. They can also penetrate tissues easily, making them effective against intra-abdominal germs. As more surgeries are performed, leading to a rise in infections, the demand for Beta-lactamases continues to grow, reinforcing their top position in this market segment.

The market is divided into five categories based on Application: Intra-abdominal Abscess, Appendicitis, Diverticulitis, diarrhea, Food Poisoning, Infection by Helicobacter Pylori, and Others. In the Intra-Abdominal Infections market, the most dominant segment is Intra-Abdominal Abscesses. These are common in clinical settings and often occur as complications from conditions like appendicitis and diverticulitis. Intra-abdominal abscesses can lead to issues, such as sepsis, which makes quick and effective treatment essential. The need for surgery and antibiotic therapy to treat these infections also boost the market.

Intra-Abdominal Infections Market- Geographical Insights

The largest region in the Intra-Abdominal Infections market is North America. This area has a high number of hospitals and advanced healthcare systems, which support the diagnosis and treatment of these infections. The rise in surgical procedures and the increasing prevalence of obesity are leading to more intra-abdominal infections.

There is also strong research and development in new treatments, driven by major healthcare companies. Patients have access to antibiotics and other therapies. The North American market is expected to grow due to increasing awareness of infection management and several contributing factors.

Intra-Abdominal Infections Market- Competitive Landscape:

The intra-abdominal infections market features several players focused on developing effective treatments for these conditions. Merck & Co. leads with a range of antibiotics and innovative therapies. Pfizer Inc. offers a variety of effective medications, while AstraZeneca is known for its research in this field.

AbbVie Inc. focuses on targeted therapies to combat infections, and Bayer AG provides a mix of treatments and supportive care. GSK (GlaxoSmithKline) is also committed to investing in new drug discoveries. As awareness of intra-abdominal infections grows, these companies compete to improve existing products and introduce new therapies, driving market growth.

Recent Developments:

In January 2024, The NPPA reduced prices of antibiotics from Cipla and Wockhardt following their off-patent status, aiming to enhance accessibility and affordability for patients.

In January 2023, BDR Pharmaceuticals launched a new generic antibiotic, Ceftazidime + Avibactam, designed to combat gram-negative infections. This combination aims to enhance treatment options for challenging bacterial pathogens, addressing growing concerns over antibiotic resistance.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Allergan (AbbVie)
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Basilea Pharmaceutica Ltd
  • Shionogi & Co., Ltd.
  • Achaogen, Inc.
  • Melinta Therapeutics, Inc.
  • Tetraphase Pharmaceuticals, Inc.
  • The Medicines Company
  • Dr. Reddy's Laboratories Ltd

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Abdominal X-ray
  • Blood Tests
  • Computed Tomography (CT)
  • Ultrasound

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Intra-abdominal Abscess
  • Appendicitis
  • Diverticulitis
  • Diarrhea
  • Food Poisoning
  • Infection by Helicobacter Pylori
  • Others

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Chloramphenicol
  • Beta Lactams
  • Quinolones
  • Aminoglycosides
  • Others

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Intra-Abdominal Infections Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Intra-Abdominal Infections Market Snippet by Diagnosis
    • 2.1.2. Intra-Abdominal Infections Market Snippet by Application
    • 2.1.3. Intra-Abdominal Infections Market Snippet by Treatment
    • 2.1.4. Intra-Abdominal Infections Market Snippet by Country
    • 2.1.5. Intra-Abdominal Infections Market Snippet by Region
  • 2.2. Competitive Insights

3. Intra-Abdominal Infections Key Market Trends

  • 3.1. Intra-Abdominal Infections Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Intra-Abdominal Infections Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Intra-Abdominal Infections Market Opportunities
  • 3.4. Intra-Abdominal Infections Market Future Trends

4. Intra-Abdominal Infections Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Intra-Abdominal Infections Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Intra-Abdominal Infections Market Landscape

  • 6.1. Intra-Abdominal Infections Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Intra-Abdominal Infections Market - By Diagnosis

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 7.1.2. Abdominal X-ray
    • 7.1.3. Blood Tests
    • 7.1.4. Computed Tomography (CT)
    • 7.1.5. Ultrasound
    • 7.1.6. Others

8. Intra-Abdominal Infections Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Intra-abdominal Abscess
    • 8.1.3. Appendicitis
    • 8.1.4. Diverticulitis
    • 8.1.5. Diarrhoea
    • 8.1.6. Food Poisoning
    • 8.1.7. Infection by Helicobacter Pylori
    • 8.1.8. Others

9. Intra-Abdominal Infections Market - By Treatment

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 9.1.2. Chloramphenicol
    • 9.1.3. Beta Lactams
    • 9.1.4. Quinolones
    • 9.1.5. Aminoglycosides
    • 9.1.6. Others

10. Intra-Abdominal Infections Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Intra-Abdominal Infections Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Intra-Abdominal Infections Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Intra-Abdominal Infections Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Intra-Abdominal Infections Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Intra-Abdominal Infections Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Intra-Abdominal Infections Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Merck & Co., Inc.
    • 11.2.3. AstraZeneca PLC
    • 11.2.4. Bayer AG
    • 11.2.5. Allergan (AbbVie)
    • 11.2.6. GlaxoSmithKline plc
    • 11.2.7. Eli Lilly and Company
    • 11.2.8. Sanofi S.A.
    • 11.2.9. F. Hoffmann-La Roche Ltd
    • 11.2.10. Johnson & Johnson
    • 11.2.11. Basilea Pharmaceutica Ltd
    • 11.2.12. Shionogi & Co., Ltd.
    • 11.2.13. Achaogen, Inc.
    • 11.2.14. Melinta Therapeutics, Inc.
    • 11.2.15. Tetraphase Pharmaceuticals, Inc.
    • 11.2.16. The Medicines Company
    • 11.2.17. Dr. Reddy's Laboratories Ltd

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us